Democratic Republic of Congo

Clinical trials show promising results for sleeping sickness drug; The latest health stories from around the world

A new drug that can treat human African trypanosomiasis—commonly known as sleeping sickness—with just one dose has shown promise in a clinical trial in the Democratic Republic of the Congo and Guinea. www.science.org/content/article/news-at-a-glance-snags-emissions-monitoring-negotiations-biodiversity-sleeping-sickness? The rare disease is caused by the parasite Trypanosoma brucei gambiense, which is transmitted by the tsetse fly. Left untreated, it is deadly. […]

Clinical trials show promising results for sleeping sickness drug; The latest health stories from around the world Read More »

Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. www.nih.gov/news-events/news-releases/monkeypox-treatment-trial-begins-democratic-republic-congo? The National Institute of Allergy

Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo Read More »

How the Ebola Outbreak in May 2018 Will Differ From the Past

On the 8th of May 2018, another Ebola epidemic was declared by the Government of the Democratic Republic of Congo. Since then, around 54 patients have presented symptoms of hemorrhagic fever with 35 confirmed Ebola cases. There have also been 25 deaths with 12 of them being confirmed as being caused by Ebola. The outbreak

How the Ebola Outbreak in May 2018 Will Differ From the Past Read More »